120 related articles for article (PubMed ID: 17305585)
1. myo-Inositol monophosphatase: a challenging target for mood stabilising drugs.
Miller DJ; Allemann RK
Mini Rev Med Chem; 2007 Feb; 7(2):107-13. PubMed ID: 17305585
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of inositol monophosphatase.
Fauroux CM; Freeman S
J Enzyme Inhib; 1999; 14(2):97-108. PubMed ID: 10445037
[TBL] [Abstract][Full Text] [Related]
3. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
Vadnal R; Parthasarathy R
Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
[TBL] [Abstract][Full Text] [Related]
4. An automated high volume assay to screen for inhibitors of myo-inositol monophosphatase from microbial fermentation broths.
Vincendon P; Corti E; Guindani A; Brunati C; Sponga F; Stefanelli S; Denaro M; Pelton P; Ganzhorn A; Islam K
J Antibiot (Tokyo); 1996 Jul; 49(7):710-2. PubMed ID: 8784438
[No Abstract] [Full Text] [Related]
5. Regulation of inositol monophosphatase in Saccharomyces cerevisiae.
Murray M; Greenberg ML
Mol Microbiol; 1997 Aug; 25(3):541-6. PubMed ID: 9302016
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of myo-inositol monophosphatase, ATCC 20928 factors A and C. Isolation, physico-chemical characterization and biological properties.
Stefanelli S; Sponga F; Ferrari P; Sottani C; Corti E; Brunati C; Islam K
J Antibiot (Tokyo); 1996 Jul; 49(7):611-6. PubMed ID: 8784418
[TBL] [Abstract][Full Text] [Related]
7. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
[TBL] [Abstract][Full Text] [Related]
8. Inositol monophosphatase inhibitors--lithium mimetics?
Atack JR
Med Res Rev; 1997 Mar; 17(2):215-24. PubMed ID: 9057165
[TBL] [Abstract][Full Text] [Related]
9. Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis.
Nigou J; Besra GS
Biochem J; 2002 Jan; 361(Pt 2):385-90. PubMed ID: 11772411
[TBL] [Abstract][Full Text] [Related]
10. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
Fujita S; Ohnishi T; Okuda S; Kobayashi R; Fukuno S; Furuta D; Kikuchi T; Yoshikawa T; Fujita N
J Mol Model; 2011 Oct; 17(10):2559-67. PubMed ID: 21213002
[TBL] [Abstract][Full Text] [Related]
11. Preparation and properties of 6-substituted cyclohexane-1,2,4-triol derivatives: mechanistic probes for the inositol monophosphatase reaction.
Schulz J; Wilkie J; Beaton MW; Miller DJ; Gani D
Biochem Soc Trans; 1998 Aug; 26(3):315-22. PubMed ID: 9765871
[No Abstract] [Full Text] [Related]
12. Kinetic characterization of enzyme forms involved in metal ion activation and inhibition of myo-inositol monophosphatase.
Strasser F; Pelton PD; Ganzhorn AJ
Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):585-93. PubMed ID: 7733900
[TBL] [Abstract][Full Text] [Related]
13. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
Pachter JA
Mol Pharmacol; 1991 Jul; 40(1):107-11. PubMed ID: 1649963
[TBL] [Abstract][Full Text] [Related]
14. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
Atack JR; Broughton HB; Pollack SJ
Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
[TBL] [Abstract][Full Text] [Related]
15. Alteration of myo-inositol monophosphatase in Alzheimer's disease brains.
Shimohama S; Tanino H; Sumida Y; Tsuda J; Fujimoto S
Neurosci Lett; 1998 Apr; 245(3):159-62. PubMed ID: 9605480
[TBL] [Abstract][Full Text] [Related]
16. A safe lithium mimetic for bipolar disorder.
Singh N; Halliday AC; Thomas JM; Kuznetsova OV; Baldwin R; Woon EC; Aley PK; Antoniadou I; Sharp T; Vasudevan SR; Churchill GC
Nat Commun; 2013; 4():1332. PubMed ID: 23299882
[TBL] [Abstract][Full Text] [Related]
17. Removal of the phosphate group in mechanism-based inhibitors of inositol monophosphatase leads to unusual inhibitory activity.
Miller DJ; Bashir-Uddin Surfraz M; Akhtar M; Gani D; Allemann RK
Org Biomol Chem; 2004 Mar; 2(5):671-88. PubMed ID: 14985807
[TBL] [Abstract][Full Text] [Related]
18. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
[TBL] [Abstract][Full Text] [Related]
19. The purification and properties of myo-inositol monophosphatase from bovine brain.
Gee NS; Ragan CI; Watling KJ; Aspley S; Jackson RG; Reid GG; Gani D; Shute JK
Biochem J; 1988 Feb; 249(3):883-9. PubMed ID: 2833231
[TBL] [Abstract][Full Text] [Related]
20. myo-Inositol monophosphatase in the brain has zinc ion-dependent tyrosine phosphatase activity.
Fujimoto S; Tsuda J; Kawakami N; Tanino H; Shimohama S
Gen Pharmacol; 1998 Sep; 31(3):469-75. PubMed ID: 9703222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
